Psoriasis
Not recruitingORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
Germany- Participants:18–64 years · 65+ years
- Substances:ORKA-001
- Sponsor:Oruka Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany930 clinical trials in Bad Bentheim, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
GermanyRO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
GermanyEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
GermanyA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
GermanyA study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis
GermanyA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
GermanyStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
GermanyA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
GermanyA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
GermanyA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
GermanyA Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis
GermanyA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Several groundbreaking trials focusing on plaque psoriasis and psoriatic arthritis are evaluating novel therapeutic approaches. Research includes comparative studies of new biological treatments and long-term safety assessments.
These studies aim to improve treatment outcomes for patients with varying severities of psoriatic conditions.
Innovative clinical trials are investigating treatments for atopic dermatitis and chronic hand eczema. Studies range from evaluating new biological therapies to investigating dose optimization strategies.
Research focuses on both adult and adolescent populations, with emphasis on long-term efficacy and safety.
Research initiatives addressing various dermatological conditions, including hidradenitis suppurativa, prurigo nodularis, and actinic keratosis. Novel therapeutic approaches are being tested.
These trials aim to develop targeted treatments for challenging skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.